PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
From:
Pharmacogenomics J. Author manuscript; available in PMC 2012 August 1.
Published in final edited form as:
Pharmacogenomics J. 2012 August; 12(4): 297–305.
Published online 2011 March 1. doi: 10.1038/tpj.2011.5

Table 2

Ashkenazi Jewish (AJ) and Sephardi Jewish (SJ) CYP2C19 allele frequencies

AlleleAJ (n =500)
SJ (n =270)
CYP2C19*2–*8 panela
CYP2C19*2–*10, *12–*17, *22 panel
CYP2C19*2–*10, *12–*17, *22 panel
Frequency95% CIFrequency95% CIFrequency95% CI
*10.8340.801–0.8670.6320.590–0.6740.7220.669–0.776
*20.1460.115–0.1770.1460.115–0.1770.0960.061–0.131
*4ANDND0.0000.000–0.0000.0040.000–0.011
*4B0.020b0.008–0.032b0.0200.008–0.0320.0110.000–0.024
*8NDND0.0000.000–0.0000.0040.000–0.011
*15NDND0.0040.000–0.0100.0040.000–0.011
*17cNDND0.1980.163–0.2330.1590.116–0.203

Abbreviations: CI, confidence interval; n, number of alleles; ND, not determined.

aPartial data from Scott et al., 2007.33
bPreviously reported as CYP2C19*4.33
cCYP2C19*17 allele frequency does not include the c.−806C>T polymorphism of the *4B haplotype.